1

1CM Inc
CNSX:EPIC

Watchlist Manager
1CM Inc
CNSX:EPIC
Watchlist
Price: 0.165 CAD -15.38%
Market Cap: 19.4m CAD

Relative Value

The Relative Value of one EPIC stock under the Base Case scenario is 0.611 CAD. Compared to the current market price of 0.165 CAD, 1CM Inc is Undervalued by 73%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

EPIC Relative Value
Base Case
0.611 CAD
Undervaluation 73%
Relative Value
Price
1
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
93
vs Industry
72
Median 3Y
1.4
Median 5Y
6.2
Industry
2.6
vs History
14
vs Industry
11
Median 3Y
-42.4
Median 5Y
-16.7
Industry
21.4
vs History
19
vs Industry
29
Median 3Y
-30.8
Median 5Y
-27.5
Industry
16.4
vs History
15
vs Industry
17
Median 3Y
-17.2
Median 5Y
-17.2
Industry
22.8
vs History
65
vs Industry
38
Median 3Y
2.7
Median 5Y
1
Industry
2.2
vs History
93
vs Industry
73
Median 3Y
1.4
Median 5Y
6.2
Industry
2.9
vs History
60
vs Industry
44
Median 3Y
6.8
Median 5Y
2
Industry
5.5
vs History
46
vs Industry
23
Median 3Y
8.2
Median 5Y
-15.9
Industry
13
vs History
39
vs Industry
18
Median 3Y
11.9
Median 5Y
-14.3
Industry
16.5
vs History
22
vs Industry
29
Median 3Y
-31
Median 5Y
-31.3
Industry
15.6
vs History
26
vs Industry
21
Median 3Y
-24.4
Median 5Y
-31.7
Industry
18.7
vs History
98
vs Industry
39
Median 3Y
2.3
Median 5Y
6
Industry
1.9

Multiples Across Competitors

EPIC Competitors Multiples
1CM Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CA
1CM Inc
CNSX:EPIC
19.4m CAD 0.3 40.1 5.1 9.3
US
Eli Lilly and Co
NYSE:LLY
1T USD 17.3 55.7 37.4 40.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
495.1B USD 5.4 19.7 16.1 20.9
CH
Roche Holding AG
SIX:ROG
270.6B CHF 4.4 28.7 12.2 14.2
UK
AstraZeneca PLC
LSE:AZN
219.5B GBP 5.1 31.4 108.8 159.2
US
Merck & Co Inc
NYSE:MRK
276.1B USD 4.3 14.5 10.3 12.2
CH
Novartis AG
SIX:NOVN
217.9B CHF 4.9 18.9 12 15.5
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK 5.3 16.1 11.2 13
IE
Endo International PLC
LSE:0Y5F
213.9B USD 92.2 -73.2 338.7 849.2
US
Pfizer Inc
NYSE:PFE
143.8B USD 2.3 14.6 7.5 10.2
P/E Multiple
Earnings Growth PEG
CA
1
1CM Inc
CNSX:EPIC
Average P/E: 26.6
40.1
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
55.7
54%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
19.7
29%
0.7
CH
Roche Holding AG
SIX:ROG
28.7
29%
1
UK
AstraZeneca PLC
LSE:AZN
31.4
37%
0.8
US
Merck & Co Inc
NYSE:MRK
14.5
15%
1
CH
Novartis AG
SIX:NOVN
18.9
17%
1.1
DK
Novo Nordisk A/S
CSE:NOVO B
16.1
3%
5.4
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -73.2 N/A N/A
US
Pfizer Inc
NYSE:PFE
14.6
27%
0.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CA
1
1CM Inc
CNSX:EPIC
Average EV/EBITDA: 400.5
5.1
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
37.4
34%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
16.1
9%
1.8
CH
Roche Holding AG
SIX:ROG
12.2
5%
2.4
UK
AstraZeneca PLC
LSE:AZN
108.8
10%
10.9
US
Merck & Co Inc
NYSE:MRK
10.3
6%
1.7
CH
Novartis AG
SIX:NOVN
12
6%
2
DK
Novo Nordisk A/S
CSE:NOVO B
11.2
1%
11.2
IE
E
Endo International PLC
LSE:0Y5F
338.7
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.5
0%
N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CA
1
1CM Inc
CNSX:EPIC
Average EV/EBIT: 1 713.3
9.3
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
40.1
36%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
20.9
15%
1.4
CH
Roche Holding AG
SIX:ROG
14.2
6%
2.4
UK
AstraZeneca PLC
LSE:AZN
159.2
23%
6.9
US
Merck & Co Inc
NYSE:MRK
12.2
8%
1.5
CH
Novartis AG
SIX:NOVN
15.5
12%
1.3
DK
Novo Nordisk A/S
CSE:NOVO B
13
0%
N/A
IE
E
Endo International PLC
LSE:0Y5F
849.2
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.2
7%
1.5